These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15853726)

  • 1. Non-viral gene delivery to the lungs.
    Kinsey BM; Densmore CL; Orson FM
    Curr Gene Ther; 2005 Apr; 5(2):181-94. PubMed ID: 15853726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient, specific and targeted delivery of genes to the lung.
    Pfeifer C; Himmel A; Geiger JP; Aneja MK; Rudolph C
    Ther Deliv; 2010 Jul; 1(1):133-48. PubMed ID: 22816124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung.
    Scheule RK; St George JA; Bagley RG; Marshall J; Kaplan JM; Akita GY; Wang KX; Lee ER; Harris DJ; Jiang C; Yew NS; Smith AE; Cheng SH
    Hum Gene Ther; 1997 Apr; 8(6):689-707. PubMed ID: 9113509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aerosol delivery of lipid:DNA complexes to lungs of rhesus monkeys.
    McDonald RJ; Liggitt HD; Roche L; Nguyen HT; Pearlman R; Raabe OG; Bussey LB; Gorman CM
    Pharm Res; 1998 May; 15(5):671-9. PubMed ID: 9619773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target specific optimization of cationic lipid-based systems for pulmonary gene therapy.
    Deshpande D; Blezinger P; Pillai R; Duguid J; Freimark B; Rolland A
    Pharm Res; 1998 Sep; 15(9):1340-7. PubMed ID: 9755883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanocomplexes for gene therapy of respiratory diseases: Targeting and overcoming the mucus barrier.
    Di Gioia S; Trapani A; Castellani S; Carbone A; Belgiovine G; Craparo EF; Puglisi G; Cavallaro G; Trapani G; Conese M
    Pulm Pharmacol Ther; 2015 Oct; 34():8-24. PubMed ID: 26192479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of gene therapy for diseases of the lung.
    Gill DR; Davies LA; Pringle IA; Hyde SC
    Cell Mol Life Sci; 2004 Feb; 61(3):355-68. PubMed ID: 14770298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficiency of non-viral gene delivery systems to rat lungs.
    Uduehi AN; Stammberger U; Frese S; Schmid RA
    Eur J Cardiothorac Surg; 2001 Jul; 20(1):159-63. PubMed ID: 11423290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy for acute lung injury.
    Brigham KL; Stecenko AA
    Intensive Care Med; 2000; 26 Suppl 1(Suppl 1):S119-23. PubMed ID: 10786968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-viral gene transfer therapy for cystic fibrosis.
    Ziady AG; Davis PB; Konstan MW
    Expert Opin Biol Ther; 2003 Jun; 3(3):449-58. PubMed ID: 12783613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors.
    Li S; Wu SP; Whitmore M; Loeffert EJ; Wang L; Watkins SC; Pitt BR; Huang L
    Am J Physiol; 1999 May; 276(5):L796-804. PubMed ID: 10330036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aerosolization of cationic lipid:pDNA complexes--in vitro optimization of nebulizer parameters for human clinical studies.
    Eastman SJ; Tousignant JD; Lukason MJ; Chu Q; Cheng SH; Scheule RK
    Hum Gene Ther; 1998 Jan; 9(1):43-52. PubMed ID: 9458241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy for Cystic Fibrosis: Improved delivery techniques and conditioning with lysophosphatidylcholine enhance lentiviral gene transfer in mouse lung airways.
    Cmielewski P; Farrow N; Devereux S; Parsons D; Donnelley M
    Exp Lung Res; 2017; 43(9-10):426-433. PubMed ID: 29236544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo gene delivery to the lung using polyethylenimine and fractured polyamidoamine dendrimers.
    Rudolph C; Lausier J; Naundorf S; Müller RH; Rosenecker J
    J Gene Med; 2000; 2(4):269-78. PubMed ID: 10953918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary gene therapy. Realistic hope for the future, or false dawn in the promised land?
    Jenkins RG; McAnulty RJ; Hart SL; Laurent GJ
    Monaldi Arch Chest Dis; 2003; 59(1):17-24. PubMed ID: 14533278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy for inherited lung disorders: an insight into pulmonary defence.
    Vadolas J; Williamson R; Ioannou PA
    Pulm Pharmacol Ther; 2002; 15(1):61-72. PubMed ID: 11969364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery systems for pulmonary gene therapy.
    Gautam A; Waldrep CJ; Densmore CL
    Am J Respir Med; 2002; 1(1):35-46. PubMed ID: 14720074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The re-emergence of aerosol gene delivery: a viable approach to lung cancer therapy.
    Densmore CL
    Curr Cancer Drug Targets; 2003 Aug; 3(4):275-86. PubMed ID: 12871058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG-free plasmid expression cassettes for cystic fibrosis gene therapy.
    Pringle IA; Hyde SC; Connolly MM; Lawton AE; Xu B; Nunez-Alonso G; Davies LA; Sumner-Jones SG; Gill DR
    Biomaterials; 2012 Oct; 33(28):6833-42. PubMed ID: 22727465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerosolized Medications for Gene and Peptide Therapy.
    Laube BL
    Respir Care; 2015 Jun; 60(6):806-21; discussion 821-4. PubMed ID: 26070576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.